ArticleContemporary oncology (Poznan, Poland)2015

Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers.

Richard E KastPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.